154 related articles for article (PubMed ID: 30114296)
1. Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis.
Muradás TC; Abbadi BL; Villela AD; Macchi FS; Bergo PF; de Freitas TF; Sperotto NDM; Timmers LFSM; Norberto de Souza O; Picada JN; Fachini J; da Silva JB; de Albuquerque NCP; Habenschus MD; Carrão DB; Rocha BA; Barbosa Junior F; de Oliveira ARM; Mascarello A; Neuenfeldf P; Nunes RJ; Morbidoni HR; Campos MM; Basso LA; Rodrigues-Junior VS
PLoS One; 2018; 13(8):e0202568. PubMed ID: 30114296
[TBL] [Abstract][Full Text] [Related]
2. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
[TBL] [Abstract][Full Text] [Related]
4. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.
Lempens P; Meehan CJ; Vandelannoote K; Fissette K; de Rijk P; Van Deun A; Rigouts L; de Jong BC
Sci Rep; 2018 Feb; 8(1):3246. PubMed ID: 29459669
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach.
Ventura TL; Calixto SD; de Azevedo Abrahim-Vieira B; de Souza AM; Mello MV; Rodrigues CR; Soter de Mariz e Miranda L; Alves de Souza RO; Leal IC; Lasunskaia EB; Muzitano MF
Molecules; 2015 May; 20(5):8072-93. PubMed ID: 25951004
[TBL] [Abstract][Full Text] [Related]
7. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
8. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
[TBL] [Abstract][Full Text] [Related]
9. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.
Abe C; Kobayashi I; Mitarai S; Wada M; Kawabe Y; Takashima T; Suzuki K; Sng LH; Wang S; Htay HH; Ogata H
J Clin Microbiol; 2008 Jul; 46(7):2263-8. PubMed ID: 18508939
[TBL] [Abstract][Full Text] [Related]
10. Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
Ramesh D; Joji A; Vijayakumar BG; Sethumadhavan A; Mani M; Kannan T
Eur J Med Chem; 2020 Jul; 198():112358. PubMed ID: 32361610
[TBL] [Abstract][Full Text] [Related]
11. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
[TBL] [Abstract][Full Text] [Related]
13. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
[TBL] [Abstract][Full Text] [Related]
14. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.
Musser JM; Kapur V; Williams DL; Kreiswirth BN; van Soolingen D; van Embden JD
J Infect Dis; 1996 Jan; 173(1):196-202. PubMed ID: 8537659
[TBL] [Abstract][Full Text] [Related]
16. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.
Dalla Costa ER; Ribeiro MO; Silva MS; Arnold LS; Rostirolla DC; Cafrune PI; Espinoza RC; Palaci M; Telles MA; Ritacco V; Suffys PN; Lopes ML; Campelo CL; Miranda SS; Kremer K; da Silva PE; Fonseca Lde S; Ho JL; Kritski AL; Rossetti ML
BMC Microbiol; 2009 Feb; 9():39. PubMed ID: 19228426
[TBL] [Abstract][Full Text] [Related]
17. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
Rouse DA; Li Z; Bai GH; Morris SL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2472-7. PubMed ID: 8585728
[TBL] [Abstract][Full Text] [Related]
19. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
[TBL] [Abstract][Full Text] [Related]
20. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
